Immune Landscape of Viral- and Carcinogen-Driven Head and Neck CancerAnthony R. Cillo, Dario A.A. Vignali, Cornelius Kürten et al.|Immunity|2020Cited by 688
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersVivian Wai Yan Lui, Jennifer R. Grandis, Raja S. Seethala et al.|Cancer Discovery|2013Cited by 590
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T. Ruffin, Tullia C. Bruno, Anthony R. Cillo et al.|Nature Communications|2021Cited by 365
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer TherapyMalabika Sen, Jennifer R. Grandis, Sufi M. Thomas et al.|Cancer Discovery|2012Cited by 313
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencingCornelius Kürten, Robert L. Ferris, Aditi Kulkarni et al.|Nature Communications|2021Cited by 303